MEDICINES DISCOVERY CATAPULT LIMITED
Get an alert when MEDICINES DISCOVERY CATAPULT LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£34m
-13.2% lowest in 3 filed years
Net assets
£39m
-0.8% lowest in 3 filed years
Employees
152
+2% highest in 3 filed years
Profit before tax
£147k
-84.4% first positive since 2024
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2026-03-31
| Metric | Trend | 2024-03-31 | 2025-03-31 | 2026-03-31 | Δ vs prior |
|---|---|---|---|---|---|
| Total income | £17,828,734 | £18,692,518 | £21,833,570 | +16.8% | |
| Operating profit | -£2,209,970 | £2,756,958 | £1,453,569 | -47.3% | |
| Profit before tax | -£1,079,179 | £945,840 | £147,427 | -84.4% | |
| Net profit | -£1,195,253 | £1,028,412 | £208,563 | -79.7% | |
| Cash | £38,991,109 | £38,998,712 | £33,865,582 | -13.2% | |
| Total assets less current liabilities | £41,281,319 | £40,285,500 | £40,315,417 | +0.1% | |
| Net assets | £40,262,829 | £39,234,418 | £38,940,101 | -0.8% | |
| Equity | £40,262,829 | £39,234,418 | £38,940,101 | -0.8% | |
| Average employees | 151 | 149 | 152 | +2% | |
| Wages | £9,145,567 | £9,612,439 | £9,990,026 | +3.9% | |
| Directors' remuneration | £449,880 | £489,262 | £476,934 | -2.5% | |
| Directors' pension contributions | £25,088 | £26,092 | £26,303 | +0.8% | |
| Highest paid director | £304,880 | £338,316 | £300,362 | -11.2% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-03-31 | 2025-03-31 | 2026-03-31 |
|---|---|---|---|---|
| Operating margin | -12.4% | 14.7% | 6.7% | |
| Net margin | -6.7% | 5.5% | 1.0% | |
| Return on capital employed | -5.4% | 6.8% | 3.6% | |
| Gearing (liabilities / total assets) | 12.0% | — | 3.4% | |
| Current ratio | 9.59x | 9.44x | 11.04x | |
| Interest cover | — | — | 55.81x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- MEDICINES DISCOVERY CATAPULT LIMITED 2016-03-01 → present
- MEDICINES TECHNOLOGIES CATAPULT LIMITED 2015-12-23 → 2016-03-01
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Consolidated group
- Auditor
- Menzies LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The forecasts indicate that the Group will have sufficient cash reserves for all its future anticipated activities. Based on this information, the Directors consider it appropriate to prepare the financial statements on a going concern basis.”
Group structure
- MEDICINES DISCOVERY CATAPULT LIMITED · parent
- Medicines Discovery Catapult Services Commercial Limited 100%
- Medicines Discovery Ventures Limited 100%
- Edge Biotech Limited 100%
Significant events
- “UK nuclear revolution powers next-generation precision cancer therapies”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
11 active · 12 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| SHERVILLE-PAYNE, Robert | Secretary | 2022-11-03 | — | — |
| BEASTALL, Paul Vernon Edward | Director | 2022-11-03 | Sep 1972 | British |
| BROWN, Robin John, Dr | Director | 2018-07-27 | Oct 1960 | British |
| BURN, John, Professor Sir | Director | 2025-01-01 | Feb 1952 | British |
| CLARKE, Graham John | Director | 2020-04-01 | Mar 1956 | British |
| FERGUSON, Michael Anthony John, Professor Sir | Director | 2025-01-01 | Feb 1957 | British |
| FLETCHER, Laura Margaret, Dr | Director | 2026-08-03 | Sep 1975 | British |
| MODI, Amira | Director | 2026-08-03 | Sep 1980 | British |
| ROBB, Lynne | Director | 2019-01-01 | Nov 1963 | British |
| STRANGE, Michael Edward, Dr | Director | 2026-01-28 | Jun 1970 | British |
| WALLCRAFT, Susan Jean | Director | 2020-04-01 | Apr 1966 | British |
Show 12 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| BELLINGHAM, Katherine Margaret | Director | 2016-06-06 | 2019-12-06 |
| BOULNOIS, Graham John | Director | 2016-01-10 | 2018-05-24 |
| BRYAN, Robert Kenneth | Director | 2015-12-23 | 2018-12-31 |
| DIX, Clive James, Dr | Director | 2016-06-06 | 2023-01-26 |
| KELLNER, Peter Jon | Director | 2016-06-06 | 2018-08-20 |
| LONGSON, Carole Margaret, Professor | Director | 2016-06-06 | 2025-06-05 |
| MACDONALD, Alistair John | Director | 2020-04-01 | 2025-09-15 |
| MARKHAM, Alexander Fred, Sir | Director | 2016-06-06 | 2025-06-05 |
| MOLLOY, Christopher Richard, Professor | Director | 2016-11-15 | 2026-01-28 |
| MORRIS, Clive Dylan, Professor | Director | 2016-06-06 | 2021-01-28 |
| PARSONS, Madeline, Professor | Director | 2025-01-01 | 2025-02-15 |
| REILLY, Christopher Fintan, Dr | Director | 2016-06-06 | 2025-06-05 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Professor Christopher Richard Molloy | Individual | Voting 25–50% | 2020-09-17 | Ceased 2021-04-13 |
| Dr Robin John Brown | Individual | Voting 25–50% | 2018-07-27 | Ceased 2021-04-13 |
| Professor Graham John Boulnois | Individual | Voting 25–50% | 2018-02-12 | Ceased 2018-05-24 |
| Mr Robert Kenneth Bryan | Individual | Voting 75–100% | 2016-04-06 | Ceased 2018-12-31 |
Filing timeline
Last 20 of 80 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-09-04 | AA | accounts | Accounts with accounts type group | |
| 2026-08-19 | AP01 | officers | Appoint person director company with name date | |
| 2026-08-17 | AP01 | officers | Appoint person director company with name date | |
| 2026-02-16 | AP01 | officers | Appoint person director company with name date | |
| 2026-02-09 | TM01 | officers | Termination director company with name termination date | |
| 2025-12-28 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-12-27 | CH01 | officers | Change person director company with change date | |
| 2025-09-29 | TM01 | officers | Termination director company with name termination date | |
| 2025-09-03 | AA | accounts | Accounts with accounts type group | |
| 2025-06-09 | TM01 | officers | Termination director company with name termination date | |
| 2025-06-09 | TM01 | officers | Termination director company with name termination date | |
| 2025-06-09 | TM01 | officers | Termination director company with name termination date | |
| 2025-03-05 | TM01 | officers | Termination director company with name termination date | |
| 2025-03-05 | AP01 | officers | Appoint person director company with name date | |
| 2025-03-04 | AP01 | officers | Appoint person director company with name date | |
| 2025-03-04 | AP01 | officers | Appoint person director company with name date | |
| 2025-01-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-12-30 | CH01 | officers | Change person director company with change date | |
| 2024-12-30 | CH01 | officers | Change person director company with change date | |
| 2024-12-30 | CH01 | officers | Change person director company with change date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 7
- Capital events
- 0
- Officers appointed
- 3
- Officers resigned
- 1
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.